Renal artery stenosis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-05-18

AUTHORS

Thomas Zeller

ABSTRACT

Opinion statementFibromuscular dysplasia (FMD) and aortoarteritis are the most frequent causes of secondary hypertension induced by renal artery stenosis (RAS). Revascularization of this disease entity usually cures arterial hypertension. Demographic evolution leads to an increasing incidence of atherosclerotic RAS, one of the major causes of end-stage renal failure. Furthermore, atherosclerotic RAS leads to deterioration of primary hypertension, progression of atherosclerosis manifestation such as occlusive and aneurysmatic peripheral artery disease, and chronic or acute organ damage such as left ventricular hypertrophy and recurrent flash pulmonary edema. Despite the lack of sufficiently powered randomized controlled trials, each hemodynamically relevant RAS (eg, ≥ 70%) should be considered for stent angioplasty in patients without end-stage ischemic nephropathy or limited life expectancy due to concomitant disease (eg, cancer). Drug-eluting stents will probably reduce the overall low in-stent restenosis rate of 10% to 20%. Interventions in patients with dialysis-dependent end-stage nephropathy are left to appropriate clinical study protocols. More... »

PAGES

90-98

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11936-007-0002-9

DOI

http://dx.doi.org/10.1007/s11936-007-0002-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1025547914

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17484811


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Abteilung Angiologie, Herz-Zentrum Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.418466.9", 
          "name": [
            "Abteilung Angiologie, Herz-Zentrum Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zeller", 
        "givenName": "Thomas", 
        "id": "sg:person.01306206724.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s003300050707", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039905631", 
          "https://doi.org/10.1007/s003300050707"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.jhh.1000599", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018663291", 
          "https://doi.org/10.1038/sj.jhh.1000599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.jhh.1001641", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017671862", 
          "https://doi.org/10.1038/sj.jhh.1001641"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-05-18", 
    "datePublishedReg": "2007-05-18", 
    "description": "Opinion statementFibromuscular dysplasia (FMD) and aortoarteritis are the most frequent causes of secondary hypertension induced by renal artery stenosis (RAS). Revascularization of this disease entity usually cures arterial hypertension. Demographic evolution leads to an increasing incidence of atherosclerotic RAS, one of the major causes of end-stage renal failure. Furthermore, atherosclerotic RAS leads to deterioration of primary hypertension, progression of atherosclerosis manifestation such as occlusive and aneurysmatic peripheral artery disease, and chronic or acute organ damage such as left ventricular hypertrophy and recurrent flash pulmonary edema. Despite the lack of sufficiently powered randomized controlled trials, each hemodynamically relevant RAS (eg, \u2265 70%) should be considered for stent angioplasty in patients without end-stage ischemic nephropathy or limited life expectancy due to concomitant disease (eg, cancer). Drug-eluting stents will probably reduce the overall low in-stent restenosis rate of 10% to 20%. Interventions in patients with dialysis-dependent end-stage nephropathy are left to appropriate clinical study protocols.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11936-007-0002-9", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1119516", 
        "issn": [
          "1092-8464", 
          "1534-3189"
        ], 
        "name": "Current Treatment Options in Cardiovascular Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "keywords": [
      "renal artery stenosis", 
      "atherosclerotic renal artery stenosis", 
      "artery stenosis", 
      "recurrent flash pulmonary edema", 
      "end-stage renal failure", 
      "acute organ damage", 
      "flash pulmonary edema", 
      "end-stage nephropathy", 
      "peripheral artery disease", 
      "limited life expectancy", 
      "stent restenosis rate", 
      "clinical study protocol", 
      "drug-eluting stents", 
      "relevant renal artery stenosis", 
      "atherosclerosis manifestations", 
      "ischemic nephropathy", 
      "secondary hypertension", 
      "arterial hypertension", 
      "concomitant diseases", 
      "renal failure", 
      "primary hypertension", 
      "artery disease", 
      "organ damage", 
      "ventricular hypertrophy", 
      "restenosis rate", 
      "pulmonary edema", 
      "stent angioplasty", 
      "study protocol", 
      "disease entity", 
      "frequent cause", 
      "hypertension", 
      "major cause", 
      "life expectancy", 
      "nephropathy", 
      "stenosis", 
      "patients", 
      "disease", 
      "overall low", 
      "cause", 
      "aortoarteritis", 
      "revascularization", 
      "angioplasty", 
      "edema", 
      "dysplasia", 
      "hypertrophy", 
      "incidence", 
      "stents", 
      "progression", 
      "trials", 
      "manifestations", 
      "intervention", 
      "expectancy", 
      "failure", 
      "damage", 
      "deterioration", 
      "entities", 
      "protocol", 
      "rate", 
      "lack", 
      "low", 
      "demographic evolution", 
      "evolution"
    ], 
    "name": "Renal artery stenosis", 
    "pagination": "90-98", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1025547914"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11936-007-0002-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17484811"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11936-007-0002-9", 
      "https://app.dimensions.ai/details/publication/pub.1025547914"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T09:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_437.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11936-007-0002-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11936-007-0002-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11936-007-0002-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11936-007-0002-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11936-007-0002-9'


 

This table displays all metadata directly associated to this object as RDF triples.

136 TRIPLES      22 PREDICATES      91 URIs      80 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11936-007-0002-9 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Nbd779649f24c4f2ba90ae808bee468b6
4 schema:citation sg:pub.10.1007/s003300050707
5 sg:pub.10.1038/sj.jhh.1000599
6 sg:pub.10.1038/sj.jhh.1001641
7 schema:datePublished 2007-05-18
8 schema:datePublishedReg 2007-05-18
9 schema:description Opinion statementFibromuscular dysplasia (FMD) and aortoarteritis are the most frequent causes of secondary hypertension induced by renal artery stenosis (RAS). Revascularization of this disease entity usually cures arterial hypertension. Demographic evolution leads to an increasing incidence of atherosclerotic RAS, one of the major causes of end-stage renal failure. Furthermore, atherosclerotic RAS leads to deterioration of primary hypertension, progression of atherosclerosis manifestation such as occlusive and aneurysmatic peripheral artery disease, and chronic or acute organ damage such as left ventricular hypertrophy and recurrent flash pulmonary edema. Despite the lack of sufficiently powered randomized controlled trials, each hemodynamically relevant RAS (eg, ≥ 70%) should be considered for stent angioplasty in patients without end-stage ischemic nephropathy or limited life expectancy due to concomitant disease (eg, cancer). Drug-eluting stents will probably reduce the overall low in-stent restenosis rate of 10% to 20%. Interventions in patients with dialysis-dependent end-stage nephropathy are left to appropriate clinical study protocols.
10 schema:genre article
11 schema:inLanguage en
12 schema:isAccessibleForFree false
13 schema:isPartOf N3fb599378c214e3eaf6b76cf194e5013
14 Nf21a054ddd5d44529fa24a72a7ec0c61
15 sg:journal.1119516
16 schema:keywords acute organ damage
17 angioplasty
18 aortoarteritis
19 arterial hypertension
20 artery disease
21 artery stenosis
22 atherosclerosis manifestations
23 atherosclerotic renal artery stenosis
24 cause
25 clinical study protocol
26 concomitant diseases
27 damage
28 demographic evolution
29 deterioration
30 disease
31 disease entity
32 drug-eluting stents
33 dysplasia
34 edema
35 end-stage nephropathy
36 end-stage renal failure
37 entities
38 evolution
39 expectancy
40 failure
41 flash pulmonary edema
42 frequent cause
43 hypertension
44 hypertrophy
45 incidence
46 intervention
47 ischemic nephropathy
48 lack
49 life expectancy
50 limited life expectancy
51 low
52 major cause
53 manifestations
54 nephropathy
55 organ damage
56 overall low
57 patients
58 peripheral artery disease
59 primary hypertension
60 progression
61 protocol
62 pulmonary edema
63 rate
64 recurrent flash pulmonary edema
65 relevant renal artery stenosis
66 renal artery stenosis
67 renal failure
68 restenosis rate
69 revascularization
70 secondary hypertension
71 stenosis
72 stent angioplasty
73 stent restenosis rate
74 stents
75 study protocol
76 trials
77 ventricular hypertrophy
78 schema:name Renal artery stenosis
79 schema:pagination 90-98
80 schema:productId N5206808052204a22b814cfeb3253c3fe
81 Nc718f29e38984911b63851e208ff3aac
82 Nfb952ed0d7374a37b7ff89f0f8d34d5c
83 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025547914
84 https://doi.org/10.1007/s11936-007-0002-9
85 schema:sdDatePublished 2022-05-10T09:55
86 schema:sdLicense https://scigraph.springernature.com/explorer/license/
87 schema:sdPublisher N268a9c1e9f62442b9b9d000a3313859a
88 schema:url https://doi.org/10.1007/s11936-007-0002-9
89 sgo:license sg:explorer/license/
90 sgo:sdDataset articles
91 rdf:type schema:ScholarlyArticle
92 N268a9c1e9f62442b9b9d000a3313859a schema:name Springer Nature - SN SciGraph project
93 rdf:type schema:Organization
94 N3fb599378c214e3eaf6b76cf194e5013 schema:issueNumber 2
95 rdf:type schema:PublicationIssue
96 N5206808052204a22b814cfeb3253c3fe schema:name pubmed_id
97 schema:value 17484811
98 rdf:type schema:PropertyValue
99 Nbd779649f24c4f2ba90ae808bee468b6 rdf:first sg:person.01306206724.74
100 rdf:rest rdf:nil
101 Nc718f29e38984911b63851e208ff3aac schema:name doi
102 schema:value 10.1007/s11936-007-0002-9
103 rdf:type schema:PropertyValue
104 Nf21a054ddd5d44529fa24a72a7ec0c61 schema:volumeNumber 9
105 rdf:type schema:PublicationVolume
106 Nfb952ed0d7374a37b7ff89f0f8d34d5c schema:name dimensions_id
107 schema:value pub.1025547914
108 rdf:type schema:PropertyValue
109 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
110 schema:name Medical and Health Sciences
111 rdf:type schema:DefinedTerm
112 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
113 schema:name Cardiorespiratory Medicine and Haematology
114 rdf:type schema:DefinedTerm
115 sg:journal.1119516 schema:issn 1092-8464
116 1534-3189
117 schema:name Current Treatment Options in Cardiovascular Medicine
118 schema:publisher Springer Nature
119 rdf:type schema:Periodical
120 sg:person.01306206724.74 schema:affiliation grid-institutes:grid.418466.9
121 schema:familyName Zeller
122 schema:givenName Thomas
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74
124 rdf:type schema:Person
125 sg:pub.10.1007/s003300050707 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039905631
126 https://doi.org/10.1007/s003300050707
127 rdf:type schema:CreativeWork
128 sg:pub.10.1038/sj.jhh.1000599 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018663291
129 https://doi.org/10.1038/sj.jhh.1000599
130 rdf:type schema:CreativeWork
131 sg:pub.10.1038/sj.jhh.1001641 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017671862
132 https://doi.org/10.1038/sj.jhh.1001641
133 rdf:type schema:CreativeWork
134 grid-institutes:grid.418466.9 schema:alternateName Abteilung Angiologie, Herz-Zentrum Bad Krozingen, Südring 15, D-79189, Bad Krozingen, Germany
135 schema:name Abteilung Angiologie, Herz-Zentrum Bad Krozingen, Südring 15, D-79189, Bad Krozingen, Germany
136 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...